New dose strategy aims to cut bleeding in cancer patients on blood thinners
Disease control
Recruiting now
This study tests whether a specially adjusted dose of the blood thinner apixaban can safely treat blood clots in cancer patients who also have low platelet counts. About 30 adults with active cancer and a recent clot will receive the adjusted dose. The goal is to see if this appr…
Phase: EARLY_PHASE1 • Sponsor: Rushad Patell • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC